Literature DB >> 7825239

Cranial computed tomographic findings in a patient with hypertensive encephalopathy in acute poststreptococcal glomerulonephritis.

I Saatçi1, R Topaloğlu.   

Abstract

A 13-year-old girl with a severe headache, blurred vision, altered mental status, seizures, high blood pressure, edema and hematuria is presented. With a previous history of upper respiratory tract infection, acute onset of edema, gross hematuria, high ASO and low C3 levels, she was diagnosed with acute poststreptococcal glomerulonephritis (APSGN) and hypertensive encephalopathy. Computed tomography (CT) revealed symmetric hypodense areas representing edema in the parieto-occipital regions. As noted in previous reports, these CT findings are of value in establishing the diagnosis of hypertensive encephalopathy. In this particular case the CT appearance and the subsequent clinical improvement without any neurological deficit supported the diagnosis of hypertensive encephalopathy due to APSGN. We emphasize that awareness of the CT findings of hypertensive encephalopathy may facilitate in making the correct diagnosis in symptomatic hypertensive patients, especially in cases with an unusual presentation or clinical course.

Entities:  

Mesh:

Year:  1994        PMID: 7825239

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  2 in total

1.  Posterior reversible leukoencephalopathy syndrome associated with acute postinfectious glomerulonephritis: systematic review.

Authors:  Corinne Orlando; Gregorio P Milani; Giacomo D Simonetti; Barbara Goeggel Simonetti; Sebastiano A G Lava; Rolf Wyttenbach; Mario G Bianchetti; Marirosa Cristallo Lacalamita
Journal:  Pediatr Nephrol       Date:  2021-09-21       Impact factor: 3.651

2.  Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis.

Authors:  Toshiyuki Ohta; Takashi Sakano; Mami Shiotsu; Takeki Furue; Hideyuki Ohtani; Yoshihisa Kinoshita; Tatsuya Mizoue; Katsuzo Kiya; Issei Tanaka
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.